logo

For the Inventor, By the Inventor

Seoul, South Korea

Eyegene Inc.

Calculating rank
USPTO Granted Patents = 11

% Expired Patents = 45.5


Forward Citations = 12

Loading Chart...
Loading Chart...

32 inventors (with patents filed for the assignee):

goldMedal Yang Je Cho (7 out of 8 patents)

silverMedal Yang-Je Cho (4 out of 4 patents)

bronzeMedal Na Gyong Lee (4 out of 4 patents)

4.  Jin-Wook Jang (3 out of 4 patents)

5.  Oh-Woong Kwon (3 out of 3 patents)

6.  Jin Wook Jang (3 out of 5 patents)

7.  Doo Sik Kim (3 out of 4 patents)

8.  Won Il Yoo (3 out of 3 patents)

9.  Kwangsung Kim (2 out of 2 patents)

10.  Doo-Sik Kim (2 out of 9 patents)

11.  Hyeong Joon Lim (2 out of 3 patents)

12.  Won-Il Yoo (2 out of 2 patents)

13.  Soo-Mee Kwon (2 out of 2 patents)

14.  Hyeong-Joon Lim (2 out of 2 patents)

15.  Bo Young Ahn (2 out of 2 patents)


11 patents:

1. 10918709 - Immune modulator and vaccine composition containing the same (2021-02-16),
2. 10874733 - Composition for enhancing immunity comprising immune modulator and cationic liposome, and use of same (2020-12-29),
3. RE48023 - Method for treating vascular-related disease (2020-06-01),
4. 9572877 - Vaccine for inducing an improved immune reaction (2017-02-21),
5. 9566323 - Vaccine for cervical cancer (2017-02-14),
6. 9290542 - Pharmaceutical composition for preventing or treating arteriosclerosis (2016-03-22),
7. 9101581 - Method for treating vascular-related disease (2015-08-11),
8. 8883987 - Immune stimulating composition comprising bacterial chromosomal DNA fragments having methylated CpG sequences and non-toxic lipopolysaccharides (2014-11-11),
9. 8372811 - Composition for treating retinopathy or glaucoma comprising thrombin derived peptides (2013-02-12),
10. 7897739 - Method for diagnosing diabetic retinopathy by single nucleotide polymorphism, DNA fragment thereof, and primer thereof (2011-03-01),
11. 7507802 - Immune stimulating and controlling composition comprising bacterial chromosomal DNA fragments and non-toxic lipopolysaccharides (2009-03-24),
Company Overview
Eyegene Inc. is a biotechnology company based in Seoul, South Korea, specializing in the development of innovative solutions for ocular diseases. The organization focuses on advanced research in gene therapy and regenerative medicine, aiming to address various vision impairments and retinal disorders. By leveraging cutting-edge technologies, Eyegene is committed to enhancing patient outcomes through targeted therapeutic approaches and novel treatment modalities in the field of ophthalmology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

11 Patents

#374 in Seoul

#1,015 in South Korea

#51,831 in the World

Seoul, KR
Seoul, South Korea

Eyegene Inc.

Forward Citations = 12

32 inventors:

goldMedal Yang Je Cho (7 out of 8 patents)

silverMedal Yang-Je Cho (4 out of 4 patents)

bronzeMedal Na Gyong Lee (4 out of 4 patents)

4.  Jin-Wook Jang (3 out of 4 patents)

5.  Oh-Woong Kwon (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Eyegene Inc.. Retrieved from https://idiyas.com/company/eyegene

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…